Prediction of Drug Approval After Phase I Clinical Trials in Oncology: RESOLVED2
{{output}}
Purpose: Drug development in oncology currently is facing a conjunction of an increasing number of antineoplastic agents (ANAs) candidate for phase I clinical trials (P1CTs) and an important attrition rate for final approval. We ... ...
